DBV Technologies Releases Half-Year Liquidity Contract Update

DBV Technologies, a late-stage biopharmaceutical company, has released its half-year report on the liquidity contract with ODDO BHF. The liquidity contract, aligned with AMF Decision No. 2021-01, began in July 2018. Initially, the account contained 41,159 shares and €432,367.25. By the end of 2025, these figures rose to 74,580 shares and €527,891.63.

As of June 30, 2026, the liquidity account held 146,321 DBV Technologies shares and €396,088.22. Between January and June 2026, a total of 1,989 buy and 2,012 sell transactions were executed, with volumes of 2,707,915 shares purchased and 2,636,174 shares sold, representing monetary values of €8.84 million in purchases and €8.70 million in sales.